Patents by Inventor Erick MORRIS

Erick MORRIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION OF A MCL-1 INHIBITOR AND MIDOSTAURIN, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
    Publication number: 20220016118
    Abstract: A combination of (a) Midostaurin, or a pharmaceutically acceptable salt thereof, or a complex thereof, or a co-crystal thereof, or a solvate, including hydrate, thereof, and (b) a Mcl-1 inhibitor and compositions and uses thereof.
    Type: Application
    Filed: November 14, 2019
    Publication date: January 20, 2022
    Inventors: Ensar HALILOVIC, Youzhen WANG, Erick MORRIS, Marina KONOPLEVA, Anna SKWARSKA
  • COMBINATION OF A BCL-2 INHIBITOR AND A MCL-1 INHIBITOR, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
    Publication number: 20190240225
    Abstract: A combination comprising a BCL-2 inhibitor and a MCL1 inhibitor, and compositions and uses thereof.
    Type: Application
    Filed: July 21, 2017
    Publication date: August 8, 2019
    Applicants: LES LABORATOIRES SERVIER, NOVARTIS AG
    Inventors: Andrew WEI, Donia MOUJALLED, Giovanna POMILIO, Ana Leticia MARAGNO, Olivier GENESTE, Audrey CLAPERON, Heiko MAACKE, Ensar HALILOVIC, Dale PORTER, Erick MORRIS, Youzhen WANG, Sneha SANGHAVI, Prakash MISTRY